Search Results 961-970 of 20827 for magnesiummagnesium

  1. Publications - Tri A. Dinh, M.D. - Mayo Clinic

    Leon MG, Carrubba AR, DeStephano CC, Heckman MG, Craver EC, Dinh TA. Impact of robotic single and dual console systems in the training of minimally invasive ...

  2. Alogliptin (oral route) - Mayo Clinic

    Adults—25 milligrams (mg) once a day. Children—Use and dose must be determined by your doctor. Missed Dose. If you miss a dose of this medicine, take it as ...

  3. Rosiglitazone and glimepiride (oral route) - Mayo Clinic

    However, the dose is usually not more than rosiglitazone 8 mg plus glimepiride 4 mg per day. Children—Use and dose must be determined by your doctor. For ...

  4. Coffee In Moderation May Offer Health Benefits - Mayo Clinic News Network

    A "cup of joe" has up to 2,000 different components, including micronutrients such as magnesium, potassium, niacin and vitamin E. Among coffee drinkers ...

  5. Givinostat (oral route) - Mayo Clinic

    Weighing 10 kg to less than 20 kg—22.2 mg or 2.5 mL 2 times a day. Children younger than 6 years of age—Use and dose must be determined by your doctor. Missed ...

  6. Rosiglitazone and metformin (oral route) - Mayo Clinic

    Dosing · Adults—rosiglitazone 4 milligrams (mg) per day plus the dose of metformin already being taken, divided into two doses. Your doctor may adjust your dose ...

  7. Dexamethasone (oral route) - Mayo Clinic

    For multiple myeloma: Adults—20 or 40 milligrams (mg) once a day. Children—Use and dose must be determined by your doctor.

  8. Clinical trials - Oncology (Medical)

    ... mg SC every 3 weeks and doxorubicin dosed at 75 mg/m2 every three weeks in patients with advanced or metastatic sarcoma who have not received doxorubicin or ...

  9. Clinical trials - Oncology (Medical)

    ... mg SC every 3 weeks and doxorubicin dosed at 75 mg/m2 every three weeks in patients with advanced or metastatic sarcoma who have not received doxorubicin or ...

  10. Clinical trials - Oncology (Medical)

    ... mg SC every 3 weeks and doxorubicin dosed at 75 mg/m2 every three weeks in patients with advanced or metastatic sarcoma who have not received doxorubicin or ...